Michel JANICOT

City:

Brussels

Country:

Belgium

Published Applications:

Last publication date:

2023-05-04

Top Assignees for applications by Michel JANICOT

The entities that hold a legal rights for patent applications filed by inventor JANICOT Michel:

ISARNA THERAPEUTICS GMBH 5 München, Germany
InteRNA Technologies B.V. 3 Nijmegen, Netherlands

Recent patent applications by JANICOT Michel

Michel JANICOT from Brussels, BE has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2023-05-04

US20230136088A1

Chemistry; metallurgy

miRNA-193a for Promoting Immunogenic Cell Death

#2 | 2022-09-01

US20220275368A1

Chemistry; metallurgy

NEW TREATMENTS INVOLVING MIRNA-193A

#3 | 2021-02-11

US20210038732A1

Human necessities

ANTICANCER MICRORNA AND LIPID FORMULATIONS THEREOF

#4 | 2019-05-16

US20190144865A1

Chemistry; metallurgy

MODIFIED TGF-BETA OLIGONUCLEOTIDE FOR USE IN A METHOD OF PREVENTING AND/OR TREATING AN OPHTHALMIC DISEASE

#5 | 2018-08-16

US20180230473A1

Chemistry; metallurgy

Modified TGF-beta oligonucleotides

#6 | 2018-03-29

US20180087055A1

Chemistry; metallurgy

MODIFIED TGF-BETA2 OLIGONUCLEOTIDES

#7 | 2017-11-02

US20170314025A1

Chemistry; metallurgy

Modified TGF-beta oligonucleotide for use in a method of preventing and/or treating an ophthalmic disease

#8 | 2016-03-17

US20160076037A1

Chemistry; metallurgy

Modified TGF-beta oligonucleotides

#9 | 2016-03-03

US20160060632A1

Chemistry; metallurgy

Modified TGF-beta2 oligonucleotides

#10 | 2016-02-11

US20160040167A1

Chemistry; metallurgy

Modified TGF-beta oligonucleotide for use in a method of preventing and/or treating an ophthalmic disease

InventorID:

1438892 ⎘